Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Double-blind Randomized Placebo-controlled Study of JBT-101 in Cystic Fibrosis
2015-002581-23Phase 2Completed
- Sponsor
- Corbus Pharmaceuticals Holdings, Inc.
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis (CF) comparing JBT-101 with Placebo (2 arms). Primary endpoint: Safety and tolerability of JBT-101. Started Oct 2015; status: completed.
02
Drugs
lenabasum
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2015-002581-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002581-23.